Wadhane Jitendra's Form 4 filing
Pyxis Oncology, Inc.PYXS · filed Sep 22, 2023
- Accession no.
- 0001209191-23-050433
- Filed
- Sep 22, 2023
- Trade date
- Sep 22, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $4.35K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wadhane JitendraCIK 0001941706 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $1.74F1 | +$4,350 | 219,437 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.7397 per share.
Referenced by the price of 1 transaction in Table I.